Testing for Bartonella is complicated by the fact that an estimated 50%-60% of thepopulation are symptom free carriers. Therefore direct testing methods (such asmicroscopy or PCR) may result in false-positives and so can serology tests aimed at measuring the humoral immune response (i.e.: Western Blot, ELISA or ELISpot). At the same time a negative test doesn’t rule out the presence of the bacteria.
Cats are the obvious examples when their blood may contain a million times more bacteria than humans and yet they are not sick from them. So the solution is not to try and find the bacteria (chances are it’s present anyway) but rather to measure the balance (homeostasis) between the pathogen and the immune system. One key aspect to this is to assess the symptoms and connect to the pathology excluding other causes. The second part of the process is to try and identify the species to determine zoonozis (non-human species) is present. The third pillar then is to measure the humoral immune response in the form of antibody levels using Western Blot or the cellular response using ELISpot tests calibrated for chronic – persisting infection that is likely to correlate to the activity of the bacteria. One of the greatest advantages of this technique is that it can be used to assess therapy efficiency and make the end of treatment decision. The following types of lab tests can be used to measure immune response:
– ELISA type tests, they usually have around 5% sensitivity in chronic infection
– ELISpot tests, they usually have around 20% sensitivity in chronic infection
– Western Blot tests, they usually have around 90% sensitivity in chronic
infection. The best tests from American laboratories are available through
www.rarediseaseslabs.eu in Europe
However, most BLMD (Bartonella Literate Medical Doctor) would use a panel approach to include direct and indirect tests, especially if one type of test is negative despite symptoms indicating a Bartonella infection.
OPTIONS FOR THERAPY
Therapy duration is usually between 6 and 34 months for chronic cases. Researchers haven’t been able to determine what factors contribute to the illness (host-response) and these factors also apply to the ability to heal, therefore there is no one-size-fits- all solution.
BLMDs usually consider the options below that are in ascending order of complexity. They prefer to start with the „lighter” therapeutic modalities and change if necessary based on control measurement of efficacy.
Buhner protocol: this one was originally created by herbalist Stephen Buhner and many webshops selling herbs have complete combination packages available. The backbone of the therapy though is Japanese Knotweed, Sida Acuta and Houttuynia.
Dr. Mozayeni’s basic protocol
Clarithromycin and Allicin
Dr. Shikhman’s protokoll
Azithromycin and Plaquenil. If this combination fails then Dr. Shikhman also uses Dr. Mozayeni’s main protocol.
Dr. Mozayeni’s main protocol
Clarithromycin and Rifampin/Rifabutin.
REFERENCES
https://en.wikipedia.org/wiki/Bartonella
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC88941/
https://www.galaxydx.com/what-is-bartonellosis/#
https://academic.oup.com/cid/article/38/1/145/355826
https://onlinelibrary.wiley.com/doi/full/10.1002/ccr3.977
https://youtu.be/rYi4z1cFVcQ
WRITTEN BY
Tamas Erdi
* This article reflects the author’s interpretation of the subject based on the references mentioned and Translational Medicine guidelines. It should not be taken as medical advice, always consult with your doctor for diagnosing and treating your condition.